greeksoup/ stock research

Heartflow, Inc. insider trading

In twelve months insiders at Heartflow bought $1.1M and sold $141M on the open market; 33 of the 38 sales were under plans set months before.

Bought on the open market$1.1M1 purchase
Sold on the open market$141M38 sales
Sales set in advance33 of 38under Rule 10b5-1 plans
Pay taken in stockNone
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

1 purchase worth $1.1M against 38 sales worth $141M; 33 of the sales were under plans set months before.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
1 open market
Sold
533 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

38 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

6 insiders traded. The most: Bain Capital Life Sciences Investors, Llc, sale outside a plan $115M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    22 October 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 22 October 202623,933$55.01$1.3 millionForm 4
    12 October 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 13 October 202638,900$49.57$1.9 millionForm 4
    18 September 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 18 September 202619,682$50.15$987,052Form 4
    18 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 18 September 202616,766$50.75$850,926Form 4
    17 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 18 September 20267,579$50.11$379,816Form 4
    15 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 15 September 2026668$50.01$33,408Form 4
    14 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 15 September 20264,593$50.24$230,744Form 4
    11 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 11 September 202629,714$50.06$1.5 millionForm 4
    11 September 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 11 September 20263,890$50.00$194,500Form 4
    10 September 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 11 September 202635,010$46.42$1.6 millionForm 4
    8 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 8 September 20266,640$50.03$332,212Form 4
    3 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 3 September 202627,540$49.69$1.4 millionForm 4
    2 September 2026Verghese VikramChief Financial OfficerSaletrading plan set in advance · Form 144 notice 3 September 20265,876$50.60$297,326Form 4
    21 August 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 21 August 202627,230$50.00$1.4 millionForm 4
    18 August 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 18 August 202632,676$45.00$1.5 millionForm 4
    17 August 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 17 August 20269,219$41.23$380,099Form 4
    14 August 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 14 August 202615,560$39.06$607,774Form 4
    10 August 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 August 202622,562$28.31$638,730Form 4
    15 July 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 15 July 20269,219$25.72$237,113Form 4
    10 July 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 July 202622,562$27.75$626,096Form 4
    24 June 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 24 June 202638,900$35.00$1.4 millionForm 4
    10 June 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 June 202622,562$28.50$643,017Form 4
    18 May 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 18 May 20269,219$28.34$261,266Form 4
    11 May 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 11 May 202622,562$29.12$657,005Form 4
    30 April 2026Bain Capital Life Sciences Investors, Llc, see footnotes10% ownerSaleafter a 3% fall over three months892,533$29.18$26.0 millionForm 4
    30 April 2026Bain Capital Life Sciences Investors, Llc, see footnotes10% ownerSaleafter a 3% fall over three months56,224$30.05$1.7 millionForm 4
    29 April 2026Bain Capital Life Sciences Investors, Llc, see footnotes10% ownerSaleafter a 5% fall over three months797,133$29.37$23.4 millionForm 4
    28 April 2026Bain Capital Life Sciences Investors, Llc, see footnotes10% ownerSaleafter a 2% fall over three months254,110$30.51$7.8 millionForm 4
    10 April 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 April 202622,562$26.72$602,857Form 4
    1 April 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 1 April 202664,533$24.64$1.6 millionForm 4
    19 March 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 19 March 202664,533$25.69$1.7 millionForm 4
    18 March 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 18 March 20269,725$25.00$243,125Form 4
    10 March 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 March 202612,837$22.66$290,886Form 4
    5 March 2026Cullivan Julie ADirectorSaletrading plan set in advance · Form 144 notice 5 March 20269,122$25.00$228,050Form 4
    12 February 2026Rogers CampbellChief Medical OfficerSaletrading plan set in advance · Form 144 notice 12 February 202665,153$24.49$1.6 millionForm 4
    10 February 2026Farquhar John C.M.Chief Executive OfficerSaletrading plan set in advance · Form 144 notice 10 February 202622,562$27.46$619,553Form 4
    5 February 2026Cullivan Julie ADirectorSaletrading plan set in advance · Form 144 notice 5 February 20268,000$27.32$218,560Form 4
    4 February 2026Bain Capital Life Sciences Investors, Llc, see footnotes10% ownerSaleafter a 19% fall over three months2,000,000$28.05$56.1 millionForm 4
    16 December 2025Lightcap Jeffrey CDirectorPurchaseafter a 15% fall over three months40,000$26.34$1.1 millionForm 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.